Experimental Alzheimer’s drug fails to deliver in closely watched clinical trial
By
McKnight's Staff
Jul 25, 2012
Alzheimer’s researchers met with disappointment Monday when officials from Pfizer announced that the experimental drug bapineuzumab failed to improve dementia symptoms in a Phase 3 trial.
